{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:05:31Z","timestamp":1791140731537,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jim.2019.04.012","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T03:06:41Z","timestamp":1556334401000},"page":"11-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Development of FAcE (Formulated Alhydrogel competitive ELISA) method for direct quantification of OAg present in Shigella sonnei GMMA-based vaccine and its optimization using Design of Experiments approach"],"prefix":"10.1016","volume":"471","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1239-8696","authenticated-orcid":false,"given":"Francesca","family":"Necchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Carducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Pisoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0665-4091","authenticated-orcid":false,"given":"Allan","family":"Saul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Rondini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2019.04.012_bb0005","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.vaccine.2016.01.012","article-title":"Multiplex immunoassay for in vitro characterization of acellular pertussis antigens in combination vaccines","volume":"34","author":"Agnolon","year":"2016","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.jim.2019.04.012_bb0010","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0264-410X(02)00166-4","article-title":"Aluminum salts in vaccines\u2014US perspective","volume":"20","author":"Baylor","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2019.04.012_bb0015","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0264-410X(00)00031-1","article-title":"Stability of aluminium-containing adjuvants during aging at room temperature","volume":"18","author":"Burrell","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2019.04.012_bb0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jim.2011.11.004","article-title":"Implementation of design of experiments (DOE) in the development and validation of a cell-based bioassay for the detection of anti-drug neutralizing antibodies in human serum","volume":"376","author":"Chen","year":"2012","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2019.04.012_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134478","article-title":"Production of a Shigella sonnei vaccine based on generalized modules for membrane antigens (GMMA), 1790GAHB","volume":"10","author":"Gerke","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2019.04.012_bb0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","article-title":"Aluminum compounds as vaccine adjuvants","volume":"32","author":"Gupta","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jim.2019.04.012_bb0035","series-title":"Vaccine Adjuvants: Preparation Methods and Research Protocols. Totowa, NJ","first-page":"65","article-title":"Aluminum compounds as vaccine adjuvants","author":"Gupta","year":"2000"},{"key":"10.1016\/j.jim.2019.04.012_bb0040","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1586\/14760584.6.5.685","article-title":"Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation","volume":"6","author":"Hem","year":"2007","journal-title":"Exp. Rev. Vaccines"},{"key":"10.1016\/j.jim.2019.04.012_bb0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jim.2008.05.012","article-title":"Optimizing ELISAs for precision and robustness using laboratory automation and statistical design of experiments","volume":"337","author":"Joelsson","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2019.04.012_bb0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jim.2013.02.019","article-title":"Use of response surface methods and path of steepest ascent to optimize ligand-binding assay sensitivity","volume":"392","author":"Joyce","year":"2013","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2019.04.012_bb0055","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/wics.73","article-title":"Response surface methodology","volume":"2","author":"Khuri","year":"2010","journal-title":"WIREs Comp Stat"},{"key":"10.1016\/j.jim.2019.04.012_bb0060","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ebiom.2017.07.013","article-title":"Safety profile and immunologic responses of a novel vaccine against Shigella sonnei administered intramuscularly, Intradermally and Intranasally: results from two parallel randomized phase 1 clinical studies in healthy adult volunteers in Europe","volume":"22","author":"Launay","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jim.2019.04.012_bb0065","series-title":"Design and Analysis of Experiments","first-page":"427","article-title":"Response surface methods and other approaches to process optimization","year":"1997"},{"key":"10.1016\/j.jim.2019.04.012_bb0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/03639045.2017.1291672","article-title":"Design of experiments (DoE) in pharmaceutical development","volume":"43","author":"N Politis","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jim.2019.04.012_bb0075","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1016\/j.biortech.2011.02.033","article-title":"Optimization, purification, characterization and antioxidant activity of an extracellular polysaccharide produced by Paenibacillus polymyxa SQR-21","volume":"102","author":"Raza","year":"2011","journal-title":"Bioresour. Technol."},{"key":"10.1016\/j.jim.2019.04.012_bb0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/jcis.1998.5648","article-title":"Effect of pH on the elution of model antigens from aluminum-containing adjuvants","volume":"205","author":"Rinella","year":"1998","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jim.2019.04.012_bb0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1006\/jcis.1997.5230","article-title":"Elutability of proteins from aluminum-containing vaccine adjuvants by treatment with surfactants","volume":"197","author":"Rinella","year":"1998","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jim.2019.04.012_bb0090","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1016104910582","article-title":"Recent advances in vaccine adjuvants","volume":"19","author":"Singh","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jim.2019.04.012_bb0095","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ab.2011.07.012","article-title":"Flow cytometry: an alternative method for direct quantification of antigens adsorbed to aluminum hydroxide adjuvant","volume":"418","author":"Ugozzoli","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jim.2019.04.012_bb0100","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1128\/CVI.00549-12","article-title":"Development and optimization of a novel assay to measure neutralizing antibodies against Clostridium difficile toxins","volume":"20","author":"Xie","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2019.04.012_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jim.2009.03.005","article-title":"Development of a Direct Alhydrogel Formulation Immunoassay (DAFIA)","volume":"344","author":"Zhu","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2019.04.012_bb0110","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1016\/j.vaccine.2009.07.067","article-title":"Use of o-phthalaldehyde assay to determine protein contents of Alhydrogel-based vaccines","volume":"27","author":"Zhu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2019.04.012_bb0115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.vaccine.2011.11.025","article-title":"Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer","volume":"30","author":"Zhu","year":"2012","journal-title":"Vaccine"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175918302953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175918302953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:26:40Z","timestamp":1762205200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175918302953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":23,"alternative-id":["S0022175918302953"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2019.04.012","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of FAcE (Formulated Alhydrogel competitive ELISA) method for direct quantification of OAg present in Shigella sonnei GMMA-based vaccine and its optimization using Design of Experiments approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2019.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}